A team of scientists has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis — often-fatal conditions that affect tens of millions of Americans.
Thomas Caranasos, M.D., is part of a team of scientists from the UNC School of Medicine and North Carolina State University (NCSU) that developed promising research toward a possible stem cell treatment for lung conditions – including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis — that are often fatal for millions of Americans.
Dr. Caranosos can be contacted through the UNC Division of Cardiothoracic Surgery at (919) 966-3381.